Literature DB >> 23500264

Nonsystem reasons for delay in door-to-balloon time and associated in-hospital mortality: a report from the National Cardiovascular Data Registry.

Rajesh V Swaminathan1, Tracy Y Wang, Lisa A Kaltenbach, Luke K Kim, Robert M Minutello, Geoffrey Bergman, S Chiu Wong, Dmitriy N Feldman.   

Abstract

OBJECTIVES: The goal of this study was to characterize nonsystem reasons for delay in door-to-balloon time (D2BT) and the impact on in-hospital mortality.
BACKGROUND: Studies have evaluated predictors of delay in D2BT, highlighting system-related issues and patient demographic characteristics. Limited data exist, however, for nonsystem reasons for delay in D2BT.
METHODS: We analyzed nonsystem reasons for delay in D2BT among 82,678 ST-segment elevation myocardial infarction patients who underwent primary percutaneous coronary intervention within 24 h of symptom onset in the CathPCI Registry from January 1, 2009, to June 30, 2011.
RESULTS: Nonsystem delays occurred in 14.7% of patients (n = 12,146). Patients with nonsystem delays were more likely to be older, female, African American, and have greater comorbidities. The in-hospital mortality for patients treated without delay was 2.5% versus 15.1% for those with delay (p < 0.01). Nonsystem delay reasons included delays in providing consent (4.4%), difficult vascular access (8.4%), difficulty crossing the lesion (18.8%), "other" (31%), and cardiac arrest/intubation (37.4%). Cardiac arrest/intubation delays had the highest in-hospital mortality (29.9%) despite the shortest time delay (median D2BT: 84 min; 25th to 75th percentile: 64 to 108 min); delays in providing consent had a relatively lower in-hospital mortality rate (9.4%) despite the longest time delay (median D2BT: 100 min; 25th to 75th percentile: 80 to 131 min). Mortality for delays due to difficult vascular access, difficulty crossing a lesion, and other was also higher (8.0%, 5.6%, and 5.9%, respectively) compared with nondelayed patients (p < 0.0001). After adjustment for baseline characteristics, in-hospital mortality remained higher for patients with nonsystem delays.
CONCLUSIONS: Nonsystem reasons for delay in D2BT in ST-segment elevation myocardial infarction patients presenting for primary percutaneous coronary intervention are common and associated with high in-hospital mortality.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23500264     DOI: 10.1016/j.jacc.2012.11.073

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Effects of Door-to-Balloon Times on Outcomes in Taiwanese Patients Receiving Primary Percutaneous Coronary Intervention: A Report of Taiwan Acute Coronary Syndrome Full Spectrum Registry.

Authors:  Chi-Cheng Lai; Kuan-Cheng Chang; Pen-Chih Liao; Chia-Tung Wu; Wen-Ter Lai; Chiung-Jen Wu; Shu-Chen Chang; Guang-Yuan Mar
Journal:  Acta Cardiol Sin       Date:  2015-05       Impact factor: 2.672

2.  STEMI time delays: a clinical perspective : Editorial comment on the article by Verweij et al.

Authors:  M-J de Boer; F Zijlstra
Journal:  Neth Heart J       Date:  2015-08       Impact factor: 2.380

3.  The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study.

Authors:  Sonja Postma; Jan-Henk E Dambrink; A T Marcel Gosselink; Jan Paul Ottervanger; Evelien Kolkman; Jurrien M Ten Berg; Harry Suryapranata; Arnoud W J van 't Hof
Journal:  Open Heart       Date:  2015-04-10

4.  The Association between Door-to-Balloon Time of Less Than 60 Minutes and Prognosis of Patients Developing ST Segment Elevation Myocardial Infarction and Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Fu-Cheng Chen; Yan-Ren Lin; Chia-Te Kung; Cheng-I Cheng; Chao-Jui Li
Journal:  Biomed Res Int       Date:  2017-04-04       Impact factor: 3.411

5.  Causes of delay in door-to-balloon time in south-east Asian patients undergoing primary percutaneous coronary intervention.

Authors:  Wen Jun Sim; An Shing Ang; Mae Chyi Tan; Wen Wei Xiang; David Foo; Kwok Kong Loh; Fahim Haider Jafary; Timothy James Watson; Paul Jau Lueng Ong; Hee Hwa Ho
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

6.  Defining unavoidable delays in primary percutaneous coronary intervention: discordance among patients excluded from National Cardiovascular Quality Registries.

Authors:  James M McCabe; Kevin F Kennedy; Robert W Yeh
Journal:  J Am Heart Assoc       Date:  2014-06-25       Impact factor: 5.501

7.  A hospital-wide system to ensure rapid treatment time across the entire spectrum of emergency percutaneous intervention.

Authors:  Umesh N Khot; Michele L Johnson-Wood; Robert VanLeeuwen; Curtis Ramsey; Monica B Khot
Journal:  Catheter Cardiovasc Interv       Date:  2015-12-23       Impact factor: 2.692

8.  Improvement in Care and Outcomes for Emergency Medical Service-Transported Patients With ST-Elevation Myocardial Infarction (STEMI) With and Without Prehospital Cardiac Arrest: A Mission: Lifeline STEMI Accelerator Study.

Authors:  Kristian Kragholm; Di Lu; Karen Chiswell; Hussein R Al-Khalidi; Mayme L Roettig; Matthew Roe; James Jollis; Christopher B Granger
Journal:  J Am Heart Assoc       Date:  2017-10-11       Impact factor: 5.501

9.  An openEHR based approach to improve the semantic interoperability of clinical data registry.

Authors:  Lingtong Min; Qi Tian; Xudong Lu; Jiye An; Huilong Duan
Journal:  BMC Med Inform Decis Mak       Date:  2018-03-22       Impact factor: 2.796

10.  Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.

Authors:  Karl Heinrich Scholz; Sebastian K G Maier; Lars S Maier; Björn Lengenfelder; Claudius Jacobshagen; Jens Jung; Claus Fleischmann; Gerald S Werner; Hans G Olbrich; Rainer Ott; Harald Mudra; Karlheinz Seidl; P Christian Schulze; Christian Weiss; Josef Haimerl; Tim Friede; Thomas Meyer
Journal:  Eur Heart J       Date:  2018-04-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.